India's Lincoln Pharmaceuticals falls on quarterly profit drop
** Lincoln Pharmaceuticals LINP.NS falls 2.4% to 517 rupees, lowest since April 7 ** Stock marks biggest intraday pct loss since August 11 ** Pharma co posts 24.1% y/y decline in September-quarter consol net profit; rev from ops rises 1.3% y/y ** More than 54,008 shares traded, 3.4x the 30-day avg ** YTD, LINP down 34.3% (Reporting by Rudra Pratap Singh in Bengaluru) ((rudrapratap.singh@thomsonreuters.com))
Recent news on LINCOLN PHARMACEUTICALS
See all newsBrief: Lincoln Pharmaceuticals Sept-Quarter Consol Net Profit 204.3 Million Rupees
India's Lincoln Pharma gains most in 15 weeks after quarterly profit jump
Brief: Lincoln Pharmaceuticals Ltd June-Quarter Consol Net Profit 362.3 Million Rupees
Brief: Lincoln Pharmaceuticals Recommends Dividend Of 1.80 Rupee Per Share For FY2026
Brief: Lincoln Pharmaceuticals Ltd Dec-Quarter Consol Net Profit 286 Million Rupees